These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21185185)

  • 1. The discovery of high affinity agonists of GPR109a with reduced serum shift and improved ADME properties.
    Imbriglio JE; DiRocco D; Bodner R; Raghavan S; Chen W; Marley D; Esser C; Holt TG; Wolff MS; Taggart AK; Waters MG; Tata JR; Colletti SL
    Bioorg Med Chem Lett; 2011 May; 21(9):2721-4. PubMed ID: 21185185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPR109a agonists. Part 2: pyrazole-acids as agonists of the human orphan G-protein coupled receptor GPR109a.
    Imbriglio JE; Chang S; Liang R; Raghavan S; Schmidt D; Smenton A; Tria S; Schrader TO; Jung JK; Esser C; Holt TG; Wolff MS; Taggart AK; Cheng K; Carballo-Jane E; Waters MG; Tata JR; Colletti SL
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4472-4. PubMed ID: 20615702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorinated pyrazole acids are agonists of the high affinity niacin receptor GPR109a.
    Skinner PJ; Cherrier MC; Webb PJ; Shin YJ; Gharbaoui T; Lindstrom A; Hong V; Tamura SY; Dang HT; Pride CC; Chen R; Richman JG; Connolly DT; Semple G
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5620-3. PubMed ID: 17804224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of orally bioavailable and novel urea agonists of the high affinity niacin receptor GPR109A.
    Shen HC; Szymonifka MJ; Kharbanda D; Deng Q; Carballo-Jane E; Wu KK; Wu TJ; Cheng K; Ren N; Cai TQ; Taggart AK; Wang J; Tong X; Waters MG; Hammond ML; Tata JR; Colletti SL
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6723-8. PubMed ID: 18029181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of pyrazolyl propionyl cyclohexenamide derivatives as full agonists for the high affinity niacin receptor GPR109A.
    Ding FX; Shen HC; Wilsie LC; Krsmanovic ML; Taggart AK; Ren N; Cai TQ; Wang J; Tong X; Holt TG; Chen Q; Waters MG; Hammond ML; Tata JR; Colletti SL
    Bioorg Med Chem Lett; 2010 Jun; 20(11):3372-5. PubMed ID: 20452209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPR109a agonists. Part 1: 5-Alkyl and 5-aryl-pyrazole-tetrazoles as agonists of the human orphan G-protein coupled receptor GPR109a.
    Imbriglio JE; Chang S; Liang R; Raghavan S; Schmidt D; Smenton A; Tria S; Schrader TO; Jung JK; Esser C; Taggart AK; Cheng K; Carballo-Jane E; Gerard Waters M; Tata JR; Colletti SL
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2121-4. PubMed ID: 19307116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of biaryl anthranilides as full agonists for the high affinity niacin receptor.
    Shen HC; Ding FX; Luell S; Forrest MJ; Carballo-Jane E; Wu KK; Wu TJ; Cheng K; Wilsie LC; Krsmanovic ML; Taggart AK; Ren N; Cai TQ; Deng Q; Chen Q; Wang J; Wolff MS; Tong X; Holt TG; Waters MG; Hammond ML; Tata JR; Colletti SL
    J Med Chem; 2007 Dec; 50(25):6303-6. PubMed ID: 17994679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of pyrazolopyrimidines as the first class of allosteric agonists for the high affinity nicotinic acid receptor GPR109A.
    Shen HC; Taggart AK; Wilsie LC; Waters MG; Hammond ML; Tata JR; Colletti SL
    Bioorg Med Chem Lett; 2008 Sep; 18(18):4948-51. PubMed ID: 18752940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analogues of acifran: agonists of the high and low affinity niacin receptors, GPR109a and GPR109b.
    Jung JK; Johnson BR; Duong T; Decaire M; Uy J; Gharbaoui T; Boatman PD; Sage CR; Chen R; Richman JG; Connolly DT; Semple G
    J Med Chem; 2007 Apr; 50(7):1445-8. PubMed ID: 17358052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrido pyrimidinones as selective agonists of the high affinity niacin receptor GPR109A: optimization of in vitro activity.
    Peters JU; Kühne H; Dehmlow H; Grether U; Conte A; Hainzl D; Hertel C; Kratochwil NA; Otteneder M; Narquizian R; Panousis CG; Ricklin F; Röver S
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5426-30. PubMed ID: 20724150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triglyceride modulation by acifran analogs: activity towards the niacin high and low affinity G protein-coupled receptors HM74A and HM74.
    Mahboubi K; Witman-Jones T; Adamus JE; Letsinger JT; Whitehouse D; Moorman AR; Sawicki D; Bergenhem N; Ross SA
    Biochem Biophys Res Commun; 2006 Feb; 340(2):482-90. PubMed ID: 16389067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonist lead identification for the high affinity niacin receptor GPR109a.
    Gharbaoui T; Skinner PJ; Shin YJ; Averbuj C; Jung JK; Johnson BR; Duong T; Decaire M; Uy J; Cherrier MC; Webb PJ; Tamura SY; Zou N; Rodriguez N; Boatman PD; Sage CR; Lindstrom A; Xu J; Schrader TO; Smith BM; Chen R; Richman JG; Connolly DT; Colletti SL; Tata JR; Semple G
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4914-9. PubMed ID: 17588745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-Alkyl-benzotriazole-5-carboxylic acids are highly selective agonists of the human orphan G-protein-coupled receptor GPR109b.
    Semple G; Skinner PJ; Cherrier MC; Webb PJ; Sage CR; Tamura SY; Chen R; Richman JG; Connolly DT
    J Med Chem; 2006 Feb; 49(4):1227-30. PubMed ID: 16480258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular modeling aided design of nicotinic acid receptor GPR109A agonists.
    Deng Q; Frie JL; Marley DM; Beresis RT; Ren N; Cai TQ; Taggart AK; Cheng K; Carballo-Jane E; Wang J; Tong X; Waters MG; Tata JR; Colletti SL
    Bioorg Med Chem Lett; 2008 Sep; 18(18):4963-7. PubMed ID: 18760600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Future of GPR109A agonists in the treatment of dyslipidaemia.
    Wanders D; Judd RL
    Diabetes Obes Metab; 2011 Aug; 13(8):685-91. PubMed ID: 21418500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of a biaryl cyclohexene carboxylic acid (MK-6892): a potent and selective high affinity niacin receptor full agonist with reduced flushing profiles in animals as a preclinical candidate.
    Shen HC; Ding FX; Raghavan S; Deng Q; Luell S; Forrest MJ; Carballo-Jane E; Wilsie LC; Krsmanovic ML; Taggart AK; Wu KK; Wu TJ; Cheng K; Ren N; Cai TQ; Chen Q; Wang J; Wolff MS; Tong X; Holt TG; Waters MG; Hammond ML; Tata JR; Colletti SL
    J Med Chem; 2010 Mar; 53(6):2666-70. PubMed ID: 20184326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel tricyclic full agonists for the G-protein-coupled niacin receptor 109A with minimized flushing in rats.
    Shen HC; Ding FX; Deng Q; Wilsie LC; Krsmanovic ML; Taggart AK; Carballo-Jane E; Ren N; Cai TQ; Wu TJ; Wu KK; Cheng K; Chen Q; Wolff MS; Tong X; Holt TG; Waters MG; Hammond ML; Tata JR; Colletti SL
    J Med Chem; 2009 Apr; 52(8):2587-602. PubMed ID: 19309152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of rat and dog models of vasodilatation and lipolysis for the calculation of a therapeutic index for GPR109A agonists.
    Carballo-Jane E; Gerckens LS; Luell S; Parlapiano AS; Wolff M; Colletti SL; Tata JR; Taggart AK; Waters MG; Richman JG; McCann ME; Forrest MJ
    J Pharmacol Toxicol Methods; 2007; 56(3):308-16. PubMed ID: 17643322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a second generation agonist of the orphan G-protein coupled receptor GPR119 with an improved profile.
    Semple G; Lehmann J; Wong A; Ren A; Bruce M; Shin YJ; Sage CR; Morgan M; Chen WC; Sebring K; Chu ZL; Leonard JN; Al-Shamma H; Grottick AJ; Du F; Liang Y; Demarest K; Jones RM
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1750-5. PubMed ID: 22264481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-Nitro-4-amino benzoic acids and 6-amino nicotinic acids are highly selective agonists of GPR109b.
    Skinner PJ; Cherrier MC; Webb PJ; Sage CR; Dang HT; Pride CC; Chen R; Tamura SY; Richman JG; Connolly DT; Semple G
    Bioorg Med Chem Lett; 2007 Dec; 17(23):6619-22. PubMed ID: 17931863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.